Last reviewed · How we verify
3L Polyethylene Glycol
At a glance
| Generic name | 3L Polyethylene Glycol |
|---|---|
| Sponsor | Changhai Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Study on the Application of Lactulose Combined with Linaclotide in Bowel Preparation for Colonoscopy (PHASE4)
- Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing (NA)
- Clinical Study of Bowel Preparation Before Colonoscopy (NA)
- Comparison of Split-dose and Single-dose Bowel Preparation Regimens Using Polyethylene Glycol Electrolyte(PEG) (NA)
- Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy (NA)
- Efficacy and Safety of Lactulose for Bowel Preparation in Patients With Inflammatory Bowel Disease (NA)
- Effect and Safety of Polyethylene Glycol Combined With Linaclotide on Colon Cleansing for Patients With Chronic Constipation (NA)
- FFI and PR Could Improve Bowel Cleansing. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 3L Polyethylene Glycol CI brief — competitive landscape report
- 3L Polyethylene Glycol updates RSS · CI watch RSS
- Changhai Hospital portfolio CI